Boston Scientific Corporation (BSX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Boston Scientific Corporation (BSX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

BSX Income Statement

Boston Scientific Corporation (BSX) annual income statement — 30-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	5.14B	5.44B	5.2B	5.29B	5.07B	5.06B	4.66B	4.56B	4.21B	4.12B	3.86B	3.73B	3.53B	3.6B	3.39B	3.24B	3.17B	3.24B	3.03B	3.13B
Revenue Growth %	1.44%	7.53%	11.58%	15.9%	20.34%	22.84%	20.93%	22.44%	19.34%	14.48%	13.78%	14.9%	11.26%	10.94%	12%	3.68%	8.12%	5.43%	9.96%	15.47%
Cost of Goods Sold	1.71B	1.59B	1.59B	1.35B	1.52B	1.64B	1.71B	1.89B	1.56B	1.53B	1.47B	1.41B	1.36B	1.32B	1.31B	1.29B	1.24B	1.26B	1.18B	1.19B
COGS % of Revenue	33.28%	29.29%	30.56%	25.5%	30.07%	32.35%	36.74%	41.44%	37.09%	37.26%	38.17%	37.93%	38.56%	36.76%	38.71%	39.7%	39.18%	38.72%	39.09%	37.93%
Gross Profit	3.43B	3.85B	3.61B	3.94B	3.54B	3.42B	2.95B	2.67B	2.65B	2.58B	2.38B	2.31B	2.17B	2.28B	2.08B	1.96B	1.93B	1.99B	1.84B	1.94B
Gross Margin %	66.72%	70.71%	69.44%	74.48%	69.93%	67.65%	63.26%	58.56%	62.91%	62.74%	61.83%	62.07%	61.44%	63.24%	61.29%	60.3%	60.82%	61.28%	60.91%	62.07%
Gross Profit Growth %	-3.22%	12.38%	22.47%	47.4%	33.76%	32.46%	23.74%	15.53%	22.2%	13.58%	14.78%	18.26%	12.4%	14.49%	12.7%	0.72%	5.24%	2.37%	10.56%	29.31%
Operating Expenses	2.45B	2.67B	2.54B	2.73B	2.49B	2.6B	2.05B	2.08B	1.97B	1.84B	1.74B	1.75B	1.61B	1.73B	1.56B	1.51B	1.47B	1.51B	1.39B	1.48B
OpEx % of Revenue	47.66%	49.06%	48.84%	51.66%	49.2%	51.47%	44.05%	45.65%	46.9%	44.61%	45.12%	47.09%	45.62%	47.93%	46.09%	46.45%	46.31%	46.58%	45.8%	47.46%
Selling, General & Admin	1.68B	1.8B	1.78B	1.83B	1.74B	1.72B	1.6B	1.61B	1.56B	1.45B	1.36B	1.38B	1.24B	1.35B	1.22B	1.16B	1.12B	1.17B	1.06B	1.15B
SG&A % of Revenue	32.76%	33.13%	34.23%	34.7%	34.37%	33.91%	34.25%	35.34%	37.11%	35.1%	35.37%	37.02%	35.21%	37.62%	35.85%	35.87%	35.27%	35.91%	35.03%	36.87%
Research & Development	520M	554M	516M	569M	514M	526M	443M	460M	407M	383M	366M	363M	356M	359M	337M	330M	339M	335M	319M	320M
R&D % of Revenue	10.12%	10.18%	9.92%	10.76%	10.15%	10.39%	9.5%	10.09%	9.67%	9.3%	9.49%	9.74%	10.09%	9.98%	9.94%	10.18%	10.69%	10.33%	10.54%	10.23%
Other Operating Expenses	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Operating Income	979M	1.18B	1.07B	1.21B	1.05B	819M	896M	589M	674M	747M	644M	558M	558M	551M	515M	449M	460M	477M	457M	457M
Operating Margin %	19.05%	21.65%	20.6%	22.81%	20.73%	16.18%	19.22%	12.91%	16.01%	18.13%	16.7%	14.98%	15.82%	15.31%	15.2%	13.85%	14.51%	14.7%	15.1%	14.61%
Operating Income Growth %	-6.76%	43.83%	19.64%	104.75%	55.79%	9.64%	39.13%	5.56%	20.79%	35.57%	25.05%	24.28%	21.3%	15.51%	12.69%	-1.75%	4.07%	-6.65%	26.94%	162.64%
EBITDA	979M	1.53B	1.42B	1.57B	1.39B	1.16B	1.22B	937M	980M	1.06B	948M	871M	859M	849M	800M	743M	744M	761M	731M	747M
EBITDA Margin %	19.05%	28.17%	27.35%	29.72%	27.48%	22.82%	26.18%	20.54%	23.28%	25.68%	24.59%	23.38%	24.36%	23.59%	23.61%	22.92%	23.47%	23.46%	24.16%	23.89%
EBITDA Growth %	-29.67%	32.73%	16.54%	67.66%	42.04%	9.17%	28.8%	7.58%	14.09%	24.62%	18.5%	17.23%	15.46%	11.56%	9.44%	-0.54%	4.2%	-1.68%	16.4%	61.34%
D&A (Non-Cash Add-back)	0	355M	351M	365M	342M	336M	325M	348M	306M	311M	304M	313M	301M	298M	285M	294M	284M	284M	274M	290M
EBIT	979M	1.16B	1.25B	956M	1.03B	1.03B	892M	723M	751M	501M	680M	572M	675M	497M	511M	463M	309M	408M	451M	208M
Net Interest Income	-100M	-96M	-90M	-90M	-87M	-90M	-87M	-117M	-83M	-81M	-72M	-45M	-67M	-71M	-67M	-60M	-64M	-63M	-291M	-87M
Interest Income	0	0	0	0	0	0	0	22M	0	0	0	22M	0	0	0	4M	1M	1M	4M	1M
Interest Expense	100M	96M	90M	90M	87M	90M	87M	139M	83M	81M	72M	67M	67M	71M	67M	64M	65M	64M	295M	88M
Other Income/Expense	-246M	-118M	90M	-506M	-111M	122M	-91M	-4M	-6M	-327M	-36M	-53M	51M	-125M	-70M	-53M	-215M	-132M	-301M	-337M
Pretax Income	733M	1.06B	1.16B	700M	939M	941M	805M	585M	668M	420M	608M	505M	609M	426M	445M	396M	245M	345M	156M	120M
Pretax Margin %	14.27%	19.48%	22.33%	13.24%	18.54%	18.59%	17.26%	12.83%	15.87%	10.19%	15.77%	13.56%	17.27%	11.84%	13.13%	12.21%	7.73%	10.63%	5.16%	3.84%
Income Tax	153M	155M	-176M	31M	183M	146M	133M	23M	200M	98M	115M	1M	105M	156M	131M	256M	57M	85M	45M	26M
Effective Tax Rate %	20.87%	14.62%	-15.15%	4.43%	19.49%	15.52%	16.52%	3.93%	29.94%	23.33%	18.91%	0.2%	17.24%	36.62%	29.44%	64.65%	23.27%	24.64%	28.85%	21.67%
Net Income	578M	907M	1.34B	668M	755M	793M	674M	566M	469M	324M	494M	504M	504M	270M	314M	140M	188M	260M	111M	94M
Net Margin %	11.25%	16.67%	25.7%	12.64%	14.91%	15.67%	14.45%	12.41%	11.14%	7.86%	12.81%	13.53%	14.29%	7.5%	9.27%	4.32%	5.93%	8.01%	3.67%	3.01%
Net Income Growth %	-23.44%	14.38%	98.37%	18.02%	60.98%	144.75%	36.44%	12.3%	-6.94%	20%	57.32%	260%	168.09%	3.85%	182.88%	48.94%	-55.13%	39.78%	-67.45%	-38.16%
Net Income (Continuing)	580M	905M	1.34B	669M	756M	795M	672M	562M	468M	322M	493M	504M	504M	270M	314M	140M	188M	260M	111M	94M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	243M	242M	240M	239M	236M	235M	233M	233M	248M	238M	242M	248M	243M	259M	259M	0	0	0	0	0
EPS (Diluted)	0.40	0.61	0.90	0.45	0.50	0.53	0.45	0.38	0.32	0.22	0.33	0.34	0.34	0.18	0.21	0.09	0.12	0.17	0.07	0.06
EPS Growth %	-20%	15.09%	99.38%	18.48%	58.58%	142.79%	35.11%	11.28%	-7.91%	21.82%	61.01%	290.5%	183.44%	4.73%	207.86%	56.91%	-57.18%	42.46%	-70.5%	-41.86%
EPS (Basic)	0.40	0.62	0.90	0.45	0.51	0.54	0.46	0.38	0.32	0.22	0.34	0.34	0.34	0.18	0.21	0.09	0.12	0.17	0.07	0.06
Diluted Shares Outstanding	1.45B	1.48B	1.5B	1.5B	1.5B	1.49B	1.49B	1.49B	1.49B	1.48B	1.48B	1.48B	1.48B	1.46B	1.45B	1.44B	1.44B	1.44B	1.44B	1.44B
Basic Shares Outstanding	1.45B	1.48B	1.48B	1.48B	1.48B	1.48B	1.48B	1.47B	1.47B	1.47B	1.47B	1.47B	1.46B	1.45B	1.44B	1.43B	1.43B	1.43B	1.43B	1.43B
Dividend Payout Ratio	-	-	-	-	-	-	-	-	4.9%	-	-	-	-	-	-	-	-	-	-	-